🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationHas anyone dealt with peptide oxidation and deamidation? Page 2

Has anyone dealt with peptide oxidation and deamidation?

ZaraB_AL Wed, Oct 15, 2025 at 12:20 PM 28 replies 1,096 viewsPage 2 of 6
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Oct 15, 2025 at 3:10 PM#6
Both Frank and Rick make excellent points and they're not mutually exclusive. The standard panel (HPLC + ESI-MS) is: - Sufficient for verifying identity and basic quality ✓ - Insufficient for full pharmaceutical characterization ✓ - The best available option for community-level testing given cost constraints ✓ - Not a substitute for proper pharmaceutical manufacturing controls ✓ My advice for the average person here: get the standard panel and use it to make informed decisions. If the mass spec confirms identity and HPLC shows >97% purity and correct content, you've eliminated the most common quality issues (wrong product, low purity, underfilling). If you want to go further, the community-funded testing initiative (see the other thread) is exploring more advanced testing like SEC for aggregation. Pooling resources makes the expensive tests accessible. For now, ESI-MS identity confirmation remains the single most important test you can get. It's the only way to conclusively prove that what's in the vial is what it claims to be. HPLC tells you purity and potency — critical information, but useless if the product isn't actually semaglutide.
Last edited: Oct 15, 2025 at 9:10 PM
15 19pam_stl, wei_SG, cory_ATX and 12 others
Reply Quote Save Share Report
pete_RVA
Member
178
890
Dec 2024
Richmond, VA
Oct 15, 2025 at 3:27 PM#7
This entire thread is going into my notes. I'm a biochem undergrad and I've learned more about practical analytical chemistry from these forum discussions than from my coursework. Quick question: on the ESI-MS spectrum for semaglutide, which charge state typically gives the strongest signal? I've been looking at some published spectra and the +4 and +5 charge states seem dominant, but I'm not sure if that's always the case.
Last edited: Oct 15, 2025 at 8:27 PM
4 16Dr.Martinez, mike_mod, SarahChen_PharmD and 1 other
Reply Quote Save Share Report
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Oct 15, 2025 at 3:44 PM#8
For semaglutide, the +4 and +5 charge states typically dominate — you're right. The exact charge state distribution depends on: - Solvent conditions (more acidic → higher charge states) - Cone voltage / source temperature settings - The protein/peptide's surface charge distribution For a ~4100 Da peptide with several basic residues (arginines and lysines), the +4 charge state (m/z ~1029) is usually the base peak (most intense). The +5 (m/z ~824) and +3 (m/z ~1372) are typically 40-70% relative intensity. Software deconvolution combines all charge states to give you the molecular weight. The beauty of ESI is that the multiply charged envelope itself is a kind of fingerprint — the spacing between peaks tells you the charge states, and from those you calculate the mass. It's mathematically elegant and practically reliable. Glad you're learning from these discussions. Analytical chemistry in the real world is way more interesting than textbook problems. If you want to go deeper, look up the "MaxEnt" deconvolution algorithm — it's what most software uses to go from raw ESI spectra to molecular weight, and it's a fascinating application of information theory to chemistry.
40 17EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 37 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register